Gene · 3384
Papers2,060
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 2,060
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Regulation of Neutrophil Migration in Patients with Sepsis: The Complexity of the Molecular Mechanisms and Their Modulation in Sepsis and the Heterogeneity of Sepsis Patients. | Cells | 2023 | 37048076 | PubTator, text mining | PubMed |
| Cerebral Malaria Model Applying Human Brain Organoids. | Cells | 2023 | 37048057 | PubTator, text mining | PubMed |
| The Interplay between Integrins and Immune Cells as a Regulator in Cancer Immunology. | Int J Mol Sci | 2023 | 37047140 | PubTator, text mining | PubMed |
| Platelets and platelet-derived vesicles as an innovative cellular and subcellular platform for managing multiple sclerosis. | Mol Biol Rep | 2023 | 37022526 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| DC-SIGN receptor is expressed by cells from cutaneous leishmaniasis lesions and differentially binds to Leishmania (Viannia) braziliensis and L. (Leishmania) amazonensis promastigotes. | Mem Inst Oswaldo Cruz | 2023 | 36995847 | PubTator, text mining | PubMed |
| Clonal associations of lymphocyte subsets and functional states revealed by single cell antigen receptor profiling of T and B cells in rheumatoid arthritis synovium. | bioRxiv | 2023 | 36993527 | PubTator, text mining | PubMed |
| Targeting tumor vasculature to improve antitumor activity of T cells armed ex vivo with T cell engaging bispecific antibody. | J Immunother Cancer | 2023 | 36990507 | PubTator, text mining | PubMed |
| Allii Macrostemonis Bulbus: A Comprehensive Review of Ethnopharmacology, Phytochemistry and Pharmacology. | Molecules | 2023 | 36985457 | PubTator, text mining | PubMed |
| Modelling a Human Blood-Brain Barrier Co-Culture Using an Ultrathin Silicon Nitride Membrane-Based Microfluidic Device. | Int J Mol Sci | 2023 | 36982697 | PubTator, text mining | PubMed |
| A transcriptomic pan-cancer signature for survival prognostication and prediction of immunotherapy response based on endothelial senescence. | J Biomed Sci | 2023 | 36978029 | PubTator, text mining | PubMed |
| Platelet, a key regulator of innate and adaptive immunity. | Front Med (Lausanne) | 2023 | 36968817 | PubTator, text mining | PubMed |
| Ezrin expression in female reproductive tissues: A review of regulation and pathophysiological implications. | Front Cell Dev Biol | 2023 | 36968198 | PubTator, text mining | PubMed |
| The impact of hyperglycemia upon BeWo trophoblast cell metabolic function: A multi-OMICS and functional metabolic analysis. | PLoS One | 2023 | 36930661 | PubTator, text mining | PubMed |
| Quantitative proteomics identifies and validates urinary biomarkers of rhabdomyosarcoma in children. | Clin Proteomics | 2023 | 36918772 | PubTator, text mining | PubMed |
| Diversity of arterial cell and phenotypic heterogeneity induced by high-fat and high-cholesterol diet. | Front Cell Dev Biol | 2023 | 36910156 | PubTator, text mining | PubMed |
| Metadherin Regulates Inflammatory Breast Cancer Invasion and Metastasis. | Int J Mol Sci | 2023 | 36902125 | PubTator, text mining | PubMed |
| Stem Cell Therapy in Diabetic Polyneuropathy: Recent Advancements and Future Directions. | Brain Sci | 2023 | 36831798 | PubTator, text mining | PubMed |
| Interactions between Platelets and Tumor Microenvironment Components in Ovarian Cancer and Their Implications for Treatment and Clinical Outcomes. | Cancers (Basel) | 2023 | 36831623 | PubTator, text mining | PubMed |
| Metastatic Progression of Human Melanoma. | Cancers (Basel) | 2023 | 36831566 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3384/papers?page=11